Competitor Analysis: EGF-R Antibodies 2015 – Biosuperiors and Biosimilars of Erbitux

Date: March 28, 2015
Pages: 50
Price:
US$ 288.00
License [?]:
Publisher: La Merie Publishing
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: CFA566ACB05EN
Leaflet:

Download PDF Leaflet

Competitor Analysis: EGF-R Antibodies 2015 – Biosuperiors and Biosimilars of Erbitux
Competitor Analysis: EGF-R Antibodies 2015 – Biosuperiors and Biosimilars of Erbitux

This Competitive Intelligence Report about EGF-R Antibodies 2015 – Biosuperiors and Biosimilars of Erbitux provides a competitor evaluation in the field of recombinant antibodies targeting epithelial growth factor receptor (EGF-R) to treat solid tumors as of March 2015. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.

The report includes a compilation of currently active projects in development of EGF-R targeting antibodies for treatment of solid tumors. In addition, the report lists company-specific R&D pipelines of EGF-R antibodies. Competitor projects are listed in a tabular format providing information on:
  • Drug Codes,
  • Target / Mechanism of Action,
  • Class of Compound,
  • Company,
  • Product Category,
  • Indication,
  • R&D Stage and
  • additional comments with a hyperlink leading to the source of information.
About Competitor Analysis Series:

The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies at low prices. The information is provided in a tabular format and fully referenced.
2014 Sales of EGF-R Antibodies
br>Marketed EGF-R Antibodies

  Erbitux Sales & Pipeline
  Vectibix Sales & Pipeline
  Nimotuzumab Pipeline

EGF-R Antibody Biosuperiors

  Engineered EGF-R Antibodies
  Bi- and Multispecific EGF-R Antibodies
  EGF-R Antibody-Drug Conjugates

EGF-R Antibody Biosimilars

  Cetuximab Biosimilars

Corporate Biosuperior & Biosimilar EGF-R Antibody Pipelines
Skip to top


Ask Your Question

Competitor Analysis: EGF-R Antibodies 2015 – Biosuperiors and Biosimilars of Erbitux
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: